Our services

Identify and unite stakeholders based on their influence and impact to foster meaningful collaboration. Engage with decision-makers to inspire positive changes in policy directions, for the greater good. Provide tailor-made solutions that enable achievements not only for our customers’ benefit, but also for society.

We subsequently develop a comprehensive decision-maker map to guide strategic messaging and engagement activities

Where appropriate, we conduct market and perception research among key stakeholders, including public officials, policymakers, medical specialists, professional associations, patient organizations, and other healthcare sector institutions

We design and implement comprehensive media strategies, encompassing articles, press releases, opinion editorials, interviews, and expert commentary

We focus on the medicine’s therapeutic indication and its societal impact, highlighting improvements in patient quality of life. Awareness and engagement are driven through the dissemination of clinical evidence, patient stories, and real-world experiences.

Communication leverages strategic channels, including seminars, conferences, face-to-face meetings, media, social platforms, and compliant partnerships with healthcare professionals and organizations

We support reimbursement strategy and market access route analysis, develop high-quality HTA and reimbursement dossiers, and provide negotiation support to secure optimal market access outcomes with payers and authorities

Collaboration commences with a precise definition of objectives and identification of target audiences. A structured work plan is established, with clearly defined, measurable outcomes.

Coordination and reporting encompass regular work meetings, monthly progress reports, media monitoring, and rapid responses to public debates or draft legislation.

Comprehensive documentation ensures all activities are fully traceable and accurately reflected in reporting

Support and manage brands in the late lifecycle phase (post–loss of exclusivity) to maximise their remaining medical and commercial value. 

Evaluate commissioning policies and commercial access schemes, and develop evidence-based market access strategies for late-lifecycle products.

Media landscapes and advocacy practices vary significantly across countries; strategies that succeed in one market may not be effective in another. We collaborate with trusted partners in Estonia, Latvia, and Lithuania, leveraging their deep local expertise and knowledge of best practices within their respective policy environments.